High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Some retirees are quietly bypassing Treasury yields and money market accounts by targeting a forgotten corner of the dividend world where payout streaks stretch back more than half a century, but the safety story on a few of these picks is far more complicated than the headline yields suggest.
While AI stocks correct, Johnson & Johnson, Altria, Coca-Cola, JPMorgan, and Apple are quietly trading near 52-week or all-time highs ahead of earnings.
In the latest trading session, Altria (MO) closed at $74.21, marking a +1.62% move from the previous day.
Altria Group, Inc. (NYSE:MO) is one of the best dividend stocks to invest in, according to Jim Simons’ Renaissance Technologies. On June 26, Altria Group, Inc. (NYSE:MO) received a significant boost after the US Food and Drug Administration issued a proposal requiring foreign tobacco manufacturers to register their establishments and list the products they sell […]
Six carefully screened dividend stocks can turn a lump sum into a self-sustaining income stream, but the real question is whether the yields on offer are generous rewards or warning signs dressed up as passive income.
Three top-performing Dividend Kings combine decades of dividend growth with strong share-price gains and bullish analyst ratings.
Zacks.com users have recently been watching Altria (MO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Altria Group stock has delivered a 126.1% return over the past 5 years, and the current valuation signals point to a different kind of tension, with both the Discounted Cash Flow (DCF) intrinsic value estimate and the market multiples suggesting the shares may still be priced below their underlying worth. For investors looking at Altria today, the question is how that apparent discount lines up with the company’s slow changing tobacco market and its push into smoke free products. Over the...
Recently, Altria Group continued expanding its smoke-free and alternative nicotine portfolio, building on its established US tobacco operations across cigarettes, cigars, oral tobacco, nicotine pouches, and other non-combustible products. This shift highlights how Altria is repositioning its long-standing tobacco business toward a broader mix of smoke-free offerings that respond to changing consumer preferences and regulatory pressures. Next, we’ll examine how Altria’s expansion of...
The constant barrage of artificial intelligence driving the hyperscaler complex massive spending spree is starting to fatigue many investors. With a war still in progress, albeit on a regional basis, in two sections of the world and government spending exploding the deficit higher, many across Wall Street are starting to agree that something has to ... The Market Could Crack This Summer: 5 Defensive High-Yielding Dividend Stocks to Buy Now
VYM and SCHD both offer low-cost dividend exposure, but differ in methodology, yield, and holdings—VYM emphasizes broad, higher-yield diversification, while SCHD focuses on stricter, dividend-growth criteria.
These high-yield stocks have long track records of dividend consistency and growth.
It’s the right time to jump in on dividend stocks. Clorox, Pfizer, Verizon and Comcast are some of the names to consider.
The 10-year Treasury yield sits at 4.49%, in the 93rd percentile of its 12-month range. That is the number every dividend investor should keep taped to their monitor this July, because it is the hurdle any equity income name has to clear before it earns a spot in the portfolio. Three large-cap payers do exactly ... 3 High-Yield Dividend Stocks to Buy in July
Altria Group is set to announce its second-quarter earnings later this month, and Wall Street expects a single-digit rise in its profits.
There's no better feeling for a dividend investor than peace of mind.
Altria (MO) reached $71.59 at the closing of the latest trading day, reflecting a -1.68% change compared to its last close.
One generates $9.1B in free cash flow; the other is growing revenue 28% annually. We compare their risk profiles and valuations.
The tobacco giant is still a resilient income investment.
The taboo against owning cigarette stocks hasn’t gone away, but new gray areas are emerging. Investors who bought BAT shares two years ago have roughly doubled their money, a better run than the Magnificent Seven. All tobacco stocks have done well over the period, including Marlboro’s U.S. maker, Altria Group which is up more than 50%.
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
Altria Group (MO) has drawn fresh attention after recent share moves, with the stock last closing at $71.88. For income focused investors, the key question is how this price lines up with fundamentals. See our latest analysis for Altria Group. Recent trading has been a little softer, with the 1 day share price return down 1.14% and the 7 day share price return down 2.93%. However, Altria Group still shows a 25.42% year to date share price return and a 5 year total shareholder return of...
A $750,000 portfolio and a $4,000 monthly income target look like a clean equation, and they are: $48,000 divided by $750,000 equals 6.4%. The trick is that 6.4% is an awkward number. It sits above what most regulated utilities pay and below what a pure business development company portfolio might offer. Hitting it reliably means ... A $750,000 Portfolio That Can Reliably Produce $4,000 a Month
Domestic cash machine vs. global growth play, one trades at half the valuation multiple.
A worker earning $80,000 full time who wants to drop to a 20-hour-a-week role paying roughly $40,000 faces one math problem: the portfolio must generate the missing $40,000 a year. Bridge income can be built across several yield tiers, and the choice between them determines how much capital is required, how much risk is assumed, ... The Portfolio That Lets You Go Part-Time Five Years Early
Medicare is not free, and the bill arrives every month for the rest of your life. The standard Part B premium in 2026 is $202.90 per month, which works out to roughly $2,435 a year per enrollee. Add Part D, a Medigap policy, and the occasional out-of-pocket charge, and most retirees end up writing checks ... What Happens When Medicare Premiums Are No Longer Your Problem?
Dividend Kings, companies with at least 50 consecutive years of dividend increases, are the quiet backbone of an income portfolio. Heading into July, three of them stand out for different reasons: One is the textbook compounding consumer staple, one is a turnaround with a catalyst on the clock and one is the high-yield income workhorse. ... 3 Dividend Kings to Buy in July
The average Social Security retirement check reached $2,081 per month as of April 2026, according to the Social Security Administration’s monthly statistical data. That figure carries the 2.8% cost-of-living adjustment that took effect in January 2026. Replacing roughly that amount with dividend income is a math problem before it is an investing problem, and the ... Social Security Pays $2,081 a Month. Here’s How Much You Need Invested to Match It.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
